✓ Credit card payment restored — secure checkout via Privacy Shield

Brimolol Eye Drop

Brimolol (brimonidine + timolol 0.5%) — fixed-combination alpha-2 agonist + beta-blocker. Twice-daily IOP control for open-angle glaucoma. Paediatric apnoea contraindication.

Medically reviewed by Morgan Ellis — Pharmacy Researcher · 8 years experience  · Last reviewed: May 2026

Buy more, save more Price per bottle
1 Bottle/s
US$13.00/bottle
US$13.00
2 Bottle/s
US$11.00/bottle · save 15%
US$22.00
3 Bottle/s
US$10.00/bottle · save 23%
US$30.00
6 Bottle/s BEST VALUE
US$8.83/bottle · save 32%
US$53.00
Encrypted checkout
Crypto pays 10% less
Discreet worldwide delivery
1,400+ customers · 50+ countries

⚡ Quick Answer — What is Brimolol Eye Drop?

Brimolol Eye Drop combines brimonidine 0.2% (alpha-2 agonist) with timolol 0.5% (beta-blocker) in one bottle for advanced glaucoma. Twice daily. Avoid in asthma, severe COPD, bradycardia, AV block, and children < 2 years.

Why order from MedsBase? Sourced from a WHO-GMP certified manufacturer · Discreet packaging · Worldwide Shipping · 1,400+ verified customer reviews

📦 Every order is covered by our Reshipment Assurance Policy — if your parcel does not arrive within 20 business days, we reship it.

Why order from MedsBase

Brimolol Eye Drop is sourced from a WHO-GMP certified manufacturer and shipped worldwide in plain, discreet packaging. Every order is covered by our Reshipment Assurance Policy — if it has not arrived after 20 business days we reship at no extra cost. Backed by 1,400+ verified customer reviews.

What is Brimolol Eye Drop?

Brimolol Eye Drop is a fixed-dose combination eye drop manufactured by Sun Pharma, containing brimonidine tartrate 0.2% and timolol maleate 0.5% in a 5 mL bottle. The two ingredients reduce aqueous humour production through complementary mechanisms — alpha-2 agonism and beta-adrenergic blockade — for additive ~25–28% IOP reduction in twice-daily dosing.

How It Works

Brimonidine activates alpha-2 receptors at the ciliary epithelium, decreasing cAMP and aqueous secretion, while also increasing uveoscleral outflow. Timolol blocks beta-1/beta-2 receptors at the same epithelium, further reducing aqueous production. The combination is more potent than either monotherapy.

Dosing

One drop in affected eye(s) twice daily, ideally 12 hours apart. Wait 5 minutes if using other eye drops. Practise punctal occlusion for 1–2 minutes after each drop. Remove contact lenses; reinsert after 15 minutes.

Triple safety check. The timolol component contraindicates $brand in asthma, severe COPD, sinus bradycardia, second/third-degree AV block, decompensated heart failure. The brimonidine component contraindicates $brand in children < 2 years (life-threatening apnoea), and is a relative contraindication with MAO inhibitors.

Side Effects

Local: conjunctival hyperaemia, allergic conjunctivitis (late-onset, brimonidine signature), stinging, blurred vision, ocular pruritus.

Systemic: dry mouth, fatigue, somnolence, hypotension, bradycardia, bronchospasm in reactive airways.

Warnings & Contraindications

  • Asthma, severe COPD — absolute (timolol)
  • Sinus bradycardia, AV block, decompensated heart failure
  • Children < 2 years — absolute (brimonidine apnoea)
  • MAO inhibitors — relative
  • Concurrent oral beta-blockers, calcium-channel blockers, digoxin
  • Pregnancy Category C — avoid
  • Severe cardiovascular disease, orthostatic hypotension

Storage

Store at 15–25°C. Discard 28 days after first opening.

Frequently Asked Questions

When should I take Brimolol Eye Drop?

Twice daily, ideally 12 hours apart.

Why combine these two drugs?

Brimonidine and timolol both reduce aqueous production but through different mechanisms. The combination is moderately additive (more than either alone) and replaces two separate bottles.

Can I use Brimolol Eye Drop if I have asthma?

No — the timolol component is contraindicated. Switch to a non-beta-blocker option.

What is punctal occlusion?

Press the inner corner of your eye for 1–2 minutes after instillation. This blocks tear drainage and reduces systemic absorption of both ingredients by ~70%.

Why is brimonidine unsafe in young children?

Brimonidine readily crosses the blood-brain barrier and can cause life-threatening apnoea, bradycardia, and hypotension in children < 2 years. Use is contraindicated in this age group.

Can I expect a late allergic reaction?

Yes — brimonidine has a characteristic late-onset allergic conjunctivitis (6–18 months in). Eye redness and itching after months of smooth use is a typical pattern.

Will I feel tired?

Brimonidine can cause systemic somnolence, dry mouth, and mild hypotension. Punctal occlusion reduces this.

Can I combine Brimolol Eye Drop with other glaucoma drops?

Yes — additive with prostaglandins and CAIs. Wait 5 minutes between bottles.

What if I take an MAO inhibitor?

Avoid — additive sedation and hypotension are possible. Disclose to your prescriber.

What if I miss a dose?

Take it as soon as you remember unless the next dose is close.

Other Eye-Care Medications

Customers viewing this product also consider these alternatives in our Eye Care range:

Medical Disclaimer

The information on this page is for educational purposes only and is not a substitute for medical advice from a qualified ophthalmologist or optometrist. Eye conditions can rapidly threaten sight — sudden vision loss, severe pain, or trauma is an ophthalmology emergency. Always consult an eye-care professional before starting, stopping, or changing any treatment.

More options in Eye Care

Ranked by recent MedsBase order volume — what other customers in this category are picking.

Strength

5 ml

Quantity

1 Bottle/s, 2 Bottle/s, 3 Bottle/s, 6 Bottle/s

Reviews

There are no reviews yet

Add a review
Brimolol Eye Drop Brimolol Eye Drop
Rating*
0/5
* Rating is required
* Answer is required
Your review
* Review is required
Name
* Name is required
Add photos or video to your review

Q & A

Ask a question
Brimolol Eye Drop Brimolol Eye Drop
Your question
* Question is required
Name
* Name is required
There are no questions yet